1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Preimplantation Genetic Screening 1.2.3 Preimplantation Genetic Diagnosis 1.3 Market by Application 1.3.1 Global Preimplantation Genetic Diagnostics (PGD) Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Fertility Clinics 1.3.3 Academic Medical Centers 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Preimplantation Genetic Diagnostics (PGD) Market Perspective (2018-2029) 2.2 Preimplantation Genetic Diagnostics (PGD) Growth Trends by Region 2.2.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Preimplantation Genetic Diagnostics (PGD) Historic Market Size by Region (2018-2023) 2.2.3 Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Region (2024-2029) 2.3 Preimplantation Genetic Diagnostics (PGD) Market Dynamics 2.3.1 Preimplantation Genetic Diagnostics (PGD) Industry Trends 2.3.2 Preimplantation Genetic Diagnostics (PGD) Market Drivers 2.3.3 Preimplantation Genetic Diagnostics (PGD) Market Challenges 2.3.4 Preimplantation Genetic Diagnostics (PGD) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Preimplantation Genetic Diagnostics (PGD) Players by Revenue 3.1.1 Global Top Preimplantation Genetic Diagnostics (PGD) Players by Revenue (2018-2023) 3.1.2 Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Players (2018-2023) 3.2 Global Preimplantation Genetic Diagnostics (PGD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Preimplantation Genetic Diagnostics (PGD) Revenue 3.4 Global Preimplantation Genetic Diagnostics (PGD) Market Concentration Ratio 3.4.1 Global Preimplantation Genetic Diagnostics (PGD) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Preimplantation Genetic Diagnostics (PGD) Revenue in 2022 3.5 Preimplantation Genetic Diagnostics (PGD) Key Players Head office and Area Served 3.6 Key Players Preimplantation Genetic Diagnostics (PGD) Product Solution and Service 3.7 Date of Enter into Preimplantation Genetic Diagnostics (PGD) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Preimplantation Genetic Diagnostics (PGD) Breakdown Data by Type 4.1 Global Preimplantation Genetic Diagnostics (PGD) Historic Market Size by Type (2018-2023) 4.2 Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Type (2024-2029) 5 Preimplantation Genetic Diagnostics (PGD) Breakdown Data by Application 5.1 Global Preimplantation Genetic Diagnostics (PGD) Historic Market Size by Application (2018-2023) 5.2 Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Preimplantation Genetic Diagnostics (PGD) Market Size (2018-2029) 6.2 North America Preimplantation Genetic Diagnostics (PGD) Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2018-2023) 6.4 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Preimplantation Genetic Diagnostics (PGD) Market Size (2018-2029) 7.2 Europe Preimplantation Genetic Diagnostics (PGD) Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2018-2023) 7.4 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size (2018-2029) 8.2 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Region (2018-2023) 8.4 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size (2018-2029) 9.2 Latin America Preimplantation Genetic Diagnostics (PGD) Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2018-2023) 9.4 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size (2018-2029) 10.2 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2018-2023) 10.4 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Illumina, Inc. 11.1.1 Illumina, Inc. Company Detail 11.1.2 Illumina, Inc. Business Overview 11.1.3 Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction 11.1.4 Illumina, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) 11.1.5 Illumina, Inc. Recent Development 11.2 Thermo Fisher Scientific Inc. 11.2.1 Thermo Fisher Scientific Inc. Company Detail 11.2.2 Thermo Fisher Scientific Inc. Business Overview 11.2.3 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Introduction 11.2.4 Thermo Fisher Scientific Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) 11.2.5 Thermo Fisher Scientific Inc. Recent Development 11.3 Agilent Technologies, Inc. 11.3.1 Agilent Technologies, Inc. Company Detail 11.3.2 Agilent Technologies, Inc. Business Overview 11.3.3 Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction 11.3.4 Agilent Technologies, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) 11.3.5 Agilent Technologies, Inc. Recent Development 11.4 Perkinelmer, Inc. 11.4.1 Perkinelmer, Inc. Company Detail 11.4.2 Perkinelmer, Inc. Business Overview 11.4.3 Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction 11.4.4 Perkinelmer, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) 11.4.5 Perkinelmer, Inc. Recent Development 11.5 Cooper Surgical 11.5.1 Cooper Surgical Company Detail 11.5.2 Cooper Surgical Business Overview 11.5.3 Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Introduction 11.5.4 Cooper Surgical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) 11.5.5 Cooper Surgical Recent Development 11.6 ABBott Laboratories 11.6.1 ABBott Laboratories Company Detail 11.6.2 ABBott Laboratories Business Overview 11.6.3 ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Introduction 11.6.4 ABBott Laboratories Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) 11.6.5 ABBott Laboratories Recent Development 11.7 Natera, Inc. 11.7.1 Natera, Inc. Company Detail 11.7.2 Natera, Inc. Business Overview 11.7.3 Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction 11.7.4 Natera, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) 11.7.5 Natera, Inc. Recent Development 11.8 Rubicon Genomics 11.8.1 Rubicon Genomics Company Detail 11.8.2 Rubicon Genomics Business Overview 11.8.3 Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Introduction 11.8.4 Rubicon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) 11.8.5 Rubicon Genomics Recent Development 11.9 Oxford Gene Technology 11.9.1 Oxford Gene Technology Company Detail 11.9.2 Oxford Gene Technology Business Overview 11.9.3 Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Introduction 11.9.4 Oxford Gene Technology Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) 11.9.5 Oxford Gene Technology Recent Development 11.10 Yikon Genomics 11.10.1 Yikon Genomics Company Detail 11.10.2 Yikon Genomics Business Overview 11.10.3 Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Introduction 11.10.4 Yikon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) 11.10.5 Yikon Genomics Recent Development 11.11 Scigene 11.11.1 Scigene Company Detail 11.11.2 Scigene Business Overview 11.11.3 Scigene Preimplantation Genetic Diagnostics (PGD) Introduction 11.11.4 Scigene Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) 11.11.5 Scigene Recent Development 11.12 Beijing Genomics Institute (BGI) 11.12.1 Beijing Genomics Institute (BGI) Company Detail 11.12.2 Beijing Genomics Institute (BGI) Business Overview 11.12.3 Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Introduction 11.12.4 Beijing Genomics Institute (BGI) Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) 11.12.5 Beijing Genomics Institute (BGI) Recent Development 11.13 Genea Limited 11.13.1 Genea Limited Company Detail 11.13.2 Genea Limited Business Overview 11.13.3 Genea Limited Preimplantation Genetic Diagnostics (PGD) Introduction 11.13.4 Genea Limited Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) 11.13.5 Genea Limited Recent Development 11.14 Hamilton Thorne 11.14.1 Hamilton Thorne Company Detail 11.14.2 Hamilton Thorne Business Overview 11.14.3 Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Introduction 11.14.4 Hamilton Thorne Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) 11.14.5 Hamilton Thorne Recent Development 11.15 FUJIFILM Irvine Scientific 11.15.1 FUJIFILM Irvine Scientific Company Detail 11.15.2 FUJIFILM Irvine Scientific Business Overview 11.15.3 FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Introduction 11.15.4 FUJIFILM Irvine Scientific Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) 11.15.5 FUJIFILM Irvine Scientific Recent Development 11.16 Nidacon International 11.16.1 Nidacon International Company Detail 11.16.2 Nidacon International Business Overview 11.16.3 Nidacon International Preimplantation Genetic Diagnostics (PGD) Introduction 11.16.4 Nidacon International Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) 11.16.5 Nidacon International Recent Development 11.17 Vitrolife AB 11.17.1 Vitrolife AB Company Detail 11.17.2 Vitrolife AB Business Overview 11.17.3 Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Introduction 11.17.4 Vitrolife AB Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) 11.17.5 Vitrolife AB Recent Development 11.18 Merck 11.18.1 Merck Company Detail 11.18.2 Merck Business Overview 11.18.3 Merck Preimplantation Genetic Diagnostics (PGD) Introduction 11.18.4 Merck Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) 11.18.5 Merck Recent Development 11.19 INVO Bioscience 11.19.1 INVO Bioscience Company Detail 11.19.2 INVO Bioscience Business Overview 11.19.3 INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Introduction 11.19.4 INVO Bioscience Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) 11.19.5 INVO Bioscience Recent Development 11.20 IVFtech 11.20.1 IVFtech Company Detail 11.20.2 IVFtech Business Overview 11.20.3 IVFtech Preimplantation Genetic Diagnostics (PGD) Introduction 11.20.4 IVFtech Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) 11.20.5 IVFtech Recent Development 11.21 Gonagen Medikal 11.21.1 Gonagen Medikal Company Detail 11.21.2 Gonagen Medikal Business Overview 11.21.3 Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Introduction 11.21.4 Gonagen Medikal Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) 11.21.5 Gonagen Medikal Recent Development 11.22 Cook Medical 11.22.1 Cook Medical Company Detail 11.22.2 Cook Medical Business Overview 11.22.3 Cook Medical Preimplantation Genetic Diagnostics (PGD) Introduction 11.22.4 Cook Medical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) 11.22.5 Cook Medical Recent Development 11.23 CellCura 11.23.1 CellCura Company Detail 11.23.2 CellCura Business Overview 11.23.3 CellCura Preimplantation Genetic Diagnostics (PGD) Introduction 11.23.4 CellCura Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) 11.23.5 CellCura Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Preimplantation Genetic Screening Table 3. Key Players of Preimplantation Genetic Diagnosis Table 4. Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 5. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 6. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Region (2018-2023) & (US$ Million) Table 7. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Region (2018-2023) Table 8. Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 9. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Region (2024-2029) Table 10. Preimplantation Genetic Diagnostics (PGD) Market Trends Table 11. Preimplantation Genetic Diagnostics (PGD) Market Drivers Table 12. Preimplantation Genetic Diagnostics (PGD) Market Challenges Table 13. Preimplantation Genetic Diagnostics (PGD) Market Restraints Table 14. Global Preimplantation Genetic Diagnostics (PGD) Revenue by Players (2018-2023) & (US$ Million) Table 15. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Players (2018-2023) Table 16. Global Top Preimplantation Genetic Diagnostics (PGD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetic Diagnostics (PGD) as of 2022) Table 17. Ranking of Global Top Preimplantation Genetic Diagnostics (PGD) Companies by Revenue (US$ Million) in 2022 Table 18. Global 5 Largest Players Market Share by Preimplantation Genetic Diagnostics (PGD) Revenue (CR5 and HHI) & (2018-2023) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Preimplantation Genetic Diagnostics (PGD) Product Solution and Service Table 21. Date of Enter into Preimplantation Genetic Diagnostics (PGD) Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2018-2023) & (US$ Million) Table 24. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Type (2018-2023) Table 25. Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 26. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Type (2024-2029) Table 27. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2018-2023) & (US$ Million) Table 28. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Application (2018-2023) Table 29. Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 30. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Application (2024-2029) Table 31. North America Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 32. North America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2018-2023) & (US$ Million) Table 33. North America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2024-2029) & (US$ Million) Table 34. Europe Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 35. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2018-2023) & (US$ Million) Table 36. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2024-2029) & (US$ Million) Table 37. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 38. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Region (2018-2023) & (US$ Million) Table 39. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Region (2024-2029) & (US$ Million) Table 40. Latin America Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 41. Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2018-2023) & (US$ Million) Table 42. Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2024-2029) & (US$ Million) Table 43. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 44. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2018-2023) & (US$ Million) Table 45. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2024-2029) & (US$ Million) Table 46. Illumina, Inc. Company Detail Table 47. Illumina, Inc. Business Overview Table 48. Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Product Table 49. Illumina, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million) Table 50. Illumina, Inc. Recent Development Table 51. Thermo Fisher Scientific Inc. Company Detail Table 52. Thermo Fisher Scientific Inc. Business Overview Table 53. Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Product Table 54. Thermo Fisher Scientific Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million) Table 55. Thermo Fisher Scientific Inc. Recent Development Table 56. Agilent Technologies, Inc. Company Detail Table 57. Agilent Technologies, Inc. Business Overview Table 58. Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Product Table 59. Agilent Technologies, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million) Table 60. Agilent Technologies, Inc. Recent Development Table 61. Perkinelmer, Inc. Company Detail Table 62. Perkinelmer, Inc. Business Overview Table 63. Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Product Table 64. Perkinelmer, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million) Table 65. Perkinelmer, Inc. Recent Development Table 66. Cooper Surgical Company Detail Table 67. Cooper Surgical Business Overview Table 68. Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Product Table 69. Cooper Surgical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million) Table 70. Cooper Surgical Recent Development Table 71. ABBott Laboratories Company Detail Table 72. ABBott Laboratories Business Overview Table 73. ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Product Table 74. ABBott Laboratories Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million) Table 75. ABBott Laboratories Recent Development Table 76. Natera, Inc. Company Detail Table 77. Natera, Inc. Business Overview Table 78. Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Product Table 79. Natera, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million) Table 80. Natera, Inc. Recent Development Table 81. Rubicon Genomics Company Detail Table 82. Rubicon Genomics Business Overview Table 83. Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Product Table 84. Rubicon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million) Table 85. Rubicon Genomics Recent Development Table 86. Oxford Gene Technology Company Detail Table 87. Oxford Gene Technology Business Overview Table 88. Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Product Table 89. Oxford Gene Technology Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million) Table 90. Oxford Gene Technology Recent Development Table 91. Yikon Genomics Company Detail Table 92. Yikon Genomics Business Overview Table 93. Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Product Table 94. Yikon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million) Table 95. Yikon Genomics Recent Development Table 96. Scigene Company Detail Table 97. Scigene Business Overview Table 98. Scigene Preimplantation Genetic Diagnostics (PGD) Product Table 99. Scigene Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million) Table 100. Scigene Recent Development Table 101. Beijing Genomics Institute (BGI) Company Detail Table 102. Beijing Genomics Institute (BGI) Business Overview Table 103. Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Product Table 104. Beijing Genomics Institute (BGI) Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million) Table 105. Beijing Genomics Institute (BGI) Recent Development Table 106. Genea Limited Company Detail Table 107. Genea Limited Business Overview Table 108. Genea Limited Preimplantation Genetic Diagnostics (PGD) Product Table 109. Genea Limited Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million) Table 110. Genea Limited Recent Development Table 111. Hamilton Thorne Company Detail Table 112. Hamilton Thorne Business Overview Table 113. Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Product Table 114. Hamilton Thorne Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million) Table 115. Hamilton Thorne Recent Development Table 116. FUJIFILM Irvine Scientific Company Detail Table 117. FUJIFILM Irvine Scientific Business Overview Table 118. FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Product Table 119. FUJIFILM Irvine Scientific Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million) Table 120. FUJIFILM Irvine Scientific Recent Development Table 121. Nidacon International Company Detail Table 122. Nidacon International Business Overview Table 123. Nidacon International Preimplantation Genetic Diagnostics (PGD) Product Table 124. Nidacon International Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million) Table 125. Nidacon International Recent Development Table 126. Vitrolife AB Company Detail Table 127. Vitrolife AB Business Overview Table 128. Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Product Table 129. Vitrolife AB Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million) Table 130. Vitrolife AB Recent Development Table 131. Merck Company Detail Table 132. Merck Business Overview Table 133. Merck Preimplantation Genetic Diagnostics (PGD) Product Table 134. Merck Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million) Table 135. Merck Recent Development Table 136. INVO Bioscience Company Detail Table 137. INVO Bioscience Business Overview Table 138. INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Product Table 139. INVO Bioscience Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million) Table 140. INVO Bioscience Recent Development Table 141. IVFtech Company Detail Table 142. IVFtech Business Overview Table 143. IVFtech Preimplantation Genetic Diagnostics (PGD) Product Table 144. IVFtech Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million) Table 145. IVFtech Recent Development Table 146. Gonagen Medikal Company Detail Table 147. Gonagen Medikal Business Overview Table 148. Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Product Table 149. Gonagen Medikal Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million) Table 150. Gonagen Medikal Recent Development Table 151. Cook Medical Company Detail Table 152. Cook Medical Business Overview Table 153. Cook Medical Preimplantation Genetic Diagnostics (PGD) Product Table 154. Cook Medical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million) Table 155. Cook Medical Recent Development Table 156. CellCura Company Detail Table 157. CellCura Business Overview Table 158. CellCura Preimplantation Genetic Diagnostics (PGD) Product Table 159. CellCura Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million) Table 160. CellCura Recent Development Table 161. Research Programs/Design for This Report Table 162. Key Data Information from Secondary Sources Table 163. Key Data Information from Primary Sources List of Figures Figure 1. Global Preimplantation Genetic Diagnostics (PGD) Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Type: 2022 VS 2029 Figure 3. Preimplantation Genetic Screening Features Figure 4. Preimplantation Genetic Diagnosis Features Figure 5. Global Preimplantation Genetic Diagnostics (PGD) Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 6. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Application: 2022 VS 2029 Figure 7. Fertility Clinics Case Studies Figure 8. Academic Medical Centers Case Studies Figure 9. Others Case Studies Figure 10. Preimplantation Genetic Diagnostics (PGD) Report Years Considered Figure 11. Global Preimplantation Genetic Diagnostics (PGD) Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 12. Global Preimplantation Genetic Diagnostics (PGD) Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 13. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Region: 2022 VS 2029 Figure 14. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Players in 2022 Figure 15. Global Top Preimplantation Genetic Diagnostics (PGD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetic Diagnostics (PGD) as of 2022) Figure 16. The Top 10 and 5 Players Market Share by Preimplantation Genetic Diagnostics (PGD) Revenue in 2022 Figure 17. North America Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 18. North America Preimplantation Genetic Diagnostics (PGD) Market Share by Country (2018-2029) Figure 19. United States Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 20. Canada Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 21. Europe Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 22. Europe Preimplantation Genetic Diagnostics (PGD) Market Share by Country (2018-2029) Figure 23. Germany Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. France Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 25. U.K. Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. Italy Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. Russia Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. Nordic Countries Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Share by Region (2018-2029) Figure 31. China Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Japan Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 33. South Korea Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. India Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. Australia Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. Latin America Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. Latin America Preimplantation Genetic Diagnostics (PGD) Market Share by Country (2018-2029) Figure 39. Mexico Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Brazil Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 41. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Share by Country (2018-2029) Figure 43. Turkey Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Saudi Arabia Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2029) & (US$ Million) Figure 45. Illumina, Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) Figure 46. Thermo Fisher Scientific Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) Figure 47. Agilent Technologies, Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) Figure 48. Perkinelmer, Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) Figure 49. Cooper Surgical Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) Figure 50. ABBott Laboratories Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) Figure 51. Natera, Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) Figure 52. Rubicon Genomics Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) Figure 53. Oxford Gene Technology Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) Figure 54. Yikon Genomics Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) Figure 55. Scigene Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) Figure 56. Beijing Genomics Institute (BGI) Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) Figure 57. Genea Limited Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) Figure 58. Hamilton Thorne Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) Figure 59. FUJIFILM Irvine Scientific Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) Figure 60. Nidacon International Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) Figure 61. Vitrolife AB Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) Figure 62. Merck Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) Figure 63. INVO Bioscience Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) Figure 64. IVFtech Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) Figure 65. Gonagen Medikal Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) Figure 66. Cook Medical Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) Figure 67. CellCura Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed

Illumina, Inc. Thermo Fisher Scientific Inc. Agilent Technologies, Inc. Perkinelmer, Inc. Cooper Surgical ABBott Laboratories Natera, Inc. Rubicon Genomics Oxford Gene Technology Yikon Genomics Scigene Beijing Genomics Institute (BGI) Genea Limited Hamilton Thorne FUJIFILM Irvine Scientific Nidacon International Vitrolife AB Merck INVO Bioscience IVFtech Gonagen Medikal Cook Medical CellCura